USD 1.03
(-1.9%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 831.4 Thousand USD | -67.37% |
2022 | 2.54 Million USD | 2450.25% |
2021 | 99.9 Thousand USD | -99.27% |
2020 | 13.69 Million USD | 15.08% |
2019 | 11.89 Million USD | 23.44% |
2018 | 9.63 Million USD | 4.87% |
2017 | 9.19 Million USD | -4.33% |
2016 | 9.6 Million USD | 23.78% |
2015 | 7.76 Million USD | 3.21% |
2014 | 7.51 Million USD | 32.03% |
2013 | 5.69 Million USD | 121632.19% |
2012 | 4678.64 USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 164.62 Thousand USD | -80.2% |
2024 Q2 | 284.5 Thousand USD | 72.82% |
2023 Q3 | 1.18 Million USD | -38.7% |
2023 FY | 831.4 Thousand USD | -67.37% |
2023 Q1 | 4.01 Million USD | 57.44% |
2023 Q2 | 1.93 Million USD | -51.88% |
2023 Q4 | 831.4 Thousand USD | -29.73% |
2022 Q3 | 799.47 Thousand USD | 1031.82% |
2022 Q4 | 2.54 Million USD | 218.7% |
2022 Q1 | 54.91 Thousand USD | -45.04% |
2022 FY | 2.54 Million USD | 2450.25% |
2022 Q2 | 70.63 Thousand USD | 28.63% |
2021 Q4 | 99.9 Thousand USD | -99.34% |
2021 FY | 99.9 Thousand USD | -99.27% |
2021 Q2 | 14.62 Million USD | 3.0% |
2021 Q3 | 15.17 Million USD | 3.81% |
2021 Q1 | 14.19 Million USD | 3.67% |
2020 Q1 | 12.47 Million USD | 4.82% |
2020 FY | 13.69 Million USD | 15.08% |
2020 Q2 | 12.84 Million USD | 3.0% |
2020 Q3 | 13.24 Million USD | 3.08% |
2020 Q4 | 13.69 Million USD | 3.41% |
2019 Q1 | 10.78 Million USD | 11.9% |
2019 FY | 11.89 Million USD | 23.44% |
2019 Q3 | 11.63 Million USD | 4.59% |
2019 Q4 | 11.89 Million USD | 2.3% |
2019 Q2 | 11.12 Million USD | 3.11% |
2018 Q3 | 9.52 Million USD | -3.14% |
2018 FY | 9.63 Million USD | 4.87% |
2018 Q1 | 9 Million USD | -2.03% |
2018 Q2 | 9.83 Million USD | 9.2% |
2018 Q4 | 9.63 Million USD | 1.2% |
2017 Q3 | 12.84 Million USD | 12.77% |
2017 FY | 9.19 Million USD | -4.33% |
2017 Q4 | 9.19 Million USD | -28.44% |
2017 Q2 | 11.39 Million USD | 11.25% |
2017 Q1 | 10.23 Million USD | 6.57% |
2016 FY | 9.6 Million USD | 23.78% |
2016 Q2 | 7.95 Million USD | 4.14% |
2016 Q1 | 7.63 Million USD | -1.64% |
2016 Q4 | 9.6 Million USD | 18.28% |
2016 Q3 | 8.12 Million USD | 2.17% |
2015 FY | 7.76 Million USD | 3.21% |
2015 Q1 | 7.79 Million USD | 3.72% |
2015 Q4 | 7.76 Million USD | 41.1% |
2015 Q3 | 5.5 Million USD | 3.56% |
2015 Q2 | 5.31 Million USD | -31.9% |
2014 Q3 | 4.77 Million USD | -24.78% |
2014 FY | 7.51 Million USD | 32.03% |
2014 Q4 | 7.51 Million USD | 57.57% |
2014 Q2 | 6.34 Million USD | 0.0% |
2014 Q1 | - USD | -100.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | 5.69 Million USD | 0.0% |
2013 FY | 5.69 Million USD | 121632.19% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 FY | 4678.64 USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acutus Medical, Inc. | 54.83 Million USD | 98.484% |
Axonics, Inc. | 82.35 Million USD | 98.991% |
INVO Bioscience, Inc. | 19.99 Million USD | 95.842% |
CVRx, Inc. | 39.28 Million USD | 97.884% |
iRhythm Technologies, Inc. | 223.04 Million USD | 99.627% |
Monogram Orthopaedics, Inc. | 3.18 Million USD | 73.871% |
MaxCyte, Inc. | 36.1 Million USD | 97.697% |
ClearPoint Neuro, Inc. | 21.48 Million USD | 96.131% |
PROCEPT BioRobotics Corporation | 123.96 Million USD | 99.329% |
Sintx Technologies, Inc. | 6.59 Million USD | 87.39% |
Accelerate Diagnostics, Inc. | 51.25 Million USD | 98.378% |
Apyx Medical Corporation | 52.31 Million USD | 98.411% |
Cutera, Inc. | 518.12 Million USD | 99.84% |
Helius Medical Technologies, Inc. | 5.34 Million USD | 84.437% |
NeuroPace, Inc. | 86.99 Million USD | 99.044% |
IRIDEX Corporation | 24.91 Million USD | 96.663% |
Tactile Systems Technology, Inc. | 87.79 Million USD | 99.053% |
enVVeno Medical Corporation | 2.43 Million USD | 65.856% |
TELA Bio, Inc. | 59.16 Million USD | 98.595% |
Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.87% |
UFP Technologies, Inc. | 118.04 Million USD | 99.296% |
Modular Medical, Inc. | 2.27 Million USD | 63.407% |
STRATA Skin Sciences, Inc. | 29.32 Million USD | 97.165% |
LENSAR, Inc. | 22.4 Million USD | 96.29% |
Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.962% |
Surmodics, Inc. | 65.82 Million USD | 98.737% |
Vivos Therapeutics, Inc. | 10.31 Million USD | 91.943% |
Inogen, Inc. | 121.38 Million USD | 99.315% |
Tivic Health Systems, Inc. | 1.67 Million USD | 50.334% |
RxSight, Inc. | 22.18 Million USD | 96.253% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -95.495% |
Lucid Diagnostics Inc. | 29.58 Million USD | 97.189% |
Nano-X Imaging Ltd. | 23.13 Million USD | 96.406% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -95.495% |
PetVivo Holdings, Inc. | 2.42 Million USD | 65.776% |
Cytek Biosciences, Inc. | 104.6 Million USD | 99.205% |
Alphatec Holdings, Inc. | 703.48 Million USD | 99.882% |
Rapid Micro Biosystems, Inc. | 25.46 Million USD | 96.735% |
Dynatronics Corporation | 11.78 Million USD | 92.942% |
TriSalus Life Sciences, Inc. | 51.66 Million USD | 98.391% |
InMode Ltd. | 75.91 Million USD | 98.905% |
Bruker Corporation | 2.83 Billion USD | 99.971% |
Movano Inc. | 5.97 Million USD | 86.078% |
Orthofix Medical Inc. | 326.58 Million USD | 99.745% |
FONAR Corporation | 57.45 Million USD | 98.553% |
BioSig Technologies, Inc. | 4.68 Million USD | 82.254% |
Envoy Medical, Inc. | 9.4 Million USD | 91.157% |
Align Technology, Inc. | 2.45 Billion USD | 99.966% |
Anika Therapeutics, Inc. | 58.36 Million USD | 98.576% |
Talis Biomedical Corporation | 29.22 Million USD | 97.155% |
Cerus Corporation | 144.3 Million USD | 99.424% |
908 Devices Inc. | 37.49 Million USD | 97.782% |
Nemaura Medical Inc. | 26.37 Million USD | 96.848% |
Outset Medical, Inc. | 190.91 Million USD | 99.565% |
NanoVibronix, Inc. | 2.68 Million USD | 69.047% |
Venus Concept Inc. | 107.1 Million USD | 99.224% |
Telesis Bio, Inc. | 40.87 Million USD | 97.966% |
Treace Medical Concepts, Inc. | 113.96 Million USD | 99.271% |
Quipt Home Medical Corp. | 136.29 Million USD | 99.39% |
IRadimed Corporation | 20.73 Million USD | 95.991% |
Tenon Medical, Inc. | 5.56 Million USD | 85.066% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 76.724% |
Pulmonx Corporation | 60.63 Million USD | 98.629% |
iCAD, Inc. | 8 Million USD | 89.609% |
QT Imaging Holdings, Inc. | 12.69 Million USD | 93.449% |
NeuroOne Medical Technologies Corporation | 1.84 Million USD | 55.009% |
Viemed Healthcare, Inc. | 40.79 Million USD | 97.962% |
SI-BONE, Inc. | 61.05 Million USD | 98.638% |
Semler Scientific, Inc. | 6.27 Million USD | 86.74% |
Biotricity, Inc. | 35.91 Million USD | 97.685% |
Cytosorbents Corporation | 29.98 Million USD | 97.227% |
DexCom, Inc. | 4.19 Billion USD | 99.98% |
ZimVie Inc. | 795.85 Million USD | 99.896% |
Aethlon Medical, Inc. | 2.47 Million USD | 66.471% |
DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 93.047% |
IceCure Medical Ltd | 4.24 Million USD | 80.424% |
PAVmed Inc | 57.13 Million USD | 98.545% |
Sight Sciences, Inc. | 46.43 Million USD | 98.21% |
Insulet Corporation | 1.85 Billion USD | 99.955% |
Profound Medical Corp. | 12.66 Million USD | 93.436% |
electroCore, Inc. | 8.94 Million USD | 90.705% |
Bioventus Inc. | 589.79 Million USD | 99.859% |
InspireMD, Inc. | 8.14 Million USD | 89.789% |
PAVmed Inc. | 57.13 Million USD | 98.545% |
Nuwellis, Inc. | 6.78 Million USD | 87.737% |
OrthoPediatrics Corp. | 72.56 Million USD | 98.854% |
DIH Holding US, Inc. Warrants | 11.95 Million USD | 93.047% |
BrainsWay Ltd. | 15.31 Million USD | 94.571% |
BIOLASE, Inc. | 35.34 Million USD | 97.648% |
Beyond Air, Inc. | 29.77 Million USD | 97.208% |
AxoGen, Inc. | 101.16 Million USD | 99.178% |
Inari Medical, Inc. | 209.32 Million USD | 99.603% |
Heart Test Laboratories, Inc. | 2.18 Million USD | 61.964% |
Autonomix Medical, Inc. Common Stock | 1.77 Million USD | 53.266% |
AdaptHealth Corp. | 3.15 Billion USD | 99.974% |
Quanterix Corporation | 78.08 Million USD | 98.935% |
Viveve Medical, Inc. | 10.84 Million USD | 92.335% |
LivaNova PLC | 1.15 Billion USD | 99.928% |
Co-Diagnostics, Inc. | 17.63 Million USD | 95.285% |
Varex Imaging Corporation | 668.6 Million USD | 99.876% |
Vivani Medical, Inc. | 25.03 Million USD | 96.679% |
ReShape Lifesciences Inc. | 4.06 Million USD | 79.542% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 76.724% |
Sensus Healthcare, Inc. | 4.88 Million USD | 82.981% |
Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.92% |
TransMedics Group, Inc. | 568.84 Million USD | 99.854% |
ReWalk Robotics Ltd. | 16.68 Million USD | 95.016% |
NeuroMetrix, Inc. | 1.33 Million USD | 37.635% |
Spectral AI, Inc. | 12.4 Million USD | 93.296% |
Hyperfine, Inc. | 9.8 Million USD | 91.516% |
Establishment Labs Holdings Inc. | 250.24 Million USD | 99.668% |
Biomerica, Inc. | 2.66 Million USD | 68.779% |
AVITA Medical, Inc. | 19.86 Million USD | 95.815% |
Bluejay Diagnostics, Inc. | 1.97 Million USD | 57.876% |
Silk Road Medical, Inc | 114.15 Million USD | 99.272% |